363. Deputy James Lawless asked the Minister for Health the status of the future provision of Respreeza for persons that suffer from alpha-1 antitrypsin deficiency; the timeframe for the completion of a health technology assessment by the National Centre for Pharmacoeconomics; the potential results of this review and the future planning of his Department regarding the results; the position regarding the continued provision of Respreeza for persons that have been using this medication for a number of years; and if he will make a statement on the matter. [40628/16]

Summary

363. Deputy James Lawless asked the Minister for Health the status of the future provision of Respreeza for persons that suffer from alpha-1 antitrypsin deficiency; the timeframe for the completion of a health technology assessment by the National Centre for Pharmacoeconomics; the potential results of this review and the future planning of his Department regarding the results; the position regarding the continued provision of Respreeza for persons that have been using this medication for a number of years; and if he will make a statement on the matter. [40628/16]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 16 December 2016

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.